An Indirect Treatment Comparison of the Cardiovascular Protective Effect of Semaglutide vs. Liraglutide in Subjects with Type 2 Diabetes

被引：0
|
作者：
Chubb, Barrie
Bog, Martin
机构：
来源：
DIABETES | 2023年 / 72卷
关键词：
D O I：
10.2337/db23-790-P
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
790-P
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Treatment evaluation of liraglutide in type 2 diabetes
    Kela, Ram
    Davies, Melanie J.
    [J]. EXPERT OPINION ON BIOLOGICAL THERAPY, 2012, 12 (11) : 1551 - 1556
  • [42] LIRAGLUTIDE: A NEW TREATMENT FOR TYPE 2 DIABETES
    Vilsboll, Tina
    [J]. DRUGS OF TODAY, 2009, 45 (02) : 101 - 113
  • [43] Oral Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes
    Husain, Mansoor
    Birkenfeld, Andreas L.
    Donsmark, Morten
    Dungan, Kathleen
    Eliaschewitz, Freddy G.
    Franco, Denise R.
    Jeppesen, Ole K.
    Lingvay, Ildiko
    Mosenzon, Ofri
    Pedersen, Sue D.
    Tack, Cees J.
    Thomsen, Mette
    Vilsboll, Tina
    Warren, Mark L.
    Bain, Stephen C.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2019, 381 (09): : 841 - 851
  • [44] The efficacy of liraglutide for treatment of type 2 diabetes
    Su, Hung-Ling
    Su, Shin-Li
    Hsu, Shang-Ren
    Tu, Shin-Te
    Hsien, Ming-Chia
    Wang, Hui-Fang
    Tseng, Ya-Yu
    Chen, Chiao-Yun
    Wu, Sin-Huei
    Shen, Pei-Shiuan
    Yau, Chun-Chun
    Chen, Hsiang-Ju
    [J]. DIABETES RESEARCH AND CLINICAL PRACTICE, 2016, 120 : S125 - S125
  • [45] Oral Semaglutide and Cardiovascular Outcomes in Type 2 Diabetes reply
    Husain, Mansoor
    Donsmark, Morten
    Bain, Stephen C.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2019, 381 (21): : 2076 - 2077
  • [46] Effects of Liraglutide on Sudomotor Function in Subjects with Type 2 Diabetes
    Casellini, Carolina M.
    Bailey, Michael D.
    Parson, Henri
    Siraj, Elias S.
    [J]. DIABETES, 2021, 70
  • [47] Tirzepatide 5, 10 and 15 mg versus injectable semaglutide 0.5 mg for the treatment of type 2 diabetes: An adjusted indirect treatment comparison
    Zaheer, Hamza
    Zaheer, Muhammad Hammad
    [J]. DIABETES RESEARCH AND CLINICAL PRACTICE, 2024, 213
  • [48] EFFECT OF GASTROINTESTINAL ADVERSE EVENTS ON TREATMENT SATISFACTION IN SEMAGLUTIDE TREATMENT OF TYPE 2 DIABETES
    Jendle, J.
    Birkenfeld, A. L.
    Silver, R.
    Uusinarkaus, K.
    Hojbjerre, L.
    Thomsen, H. F.
    Davies, M.
    [J]. VALUE IN HEALTH, 2017, 20 (09) : A484 - A484
  • [49] The pharmacological treatment of type 2 diabetes and cardiovascular prevention: what does liraglutide add?
    Reboldi, Gianpaolo
    [J]. GIORNALE ITALIANO DI CARDIOLOGIA, 2009, 10 (07) : 434 - 447
  • [50] Tirzepatide vs. Semaglutide for Weight Loss in Patients With Type 2 Diabetes Mellitus - A Value for Money Analysis
    Azuri, Joseph
    Hammerman, Ariel
    Aboalhasan, Enis
    Sluckis, Ben
    Arbel, Ronen
    [J]. CIRCULATION, 2022, 146
12345